Gene-editing treatment for sickle cell awaits FDA approval : Shots - Health News
The Food and Drug Administration may soon approve a therapy that uses the gene-editing technique called CRISPR to treat sickle cell disease. It would mark the first time gene editing moves from the lab into clinical use. A committee of advisers to the FDA meets Tuesday to review the scientific…
#fda #exacel #boston #victoriagray #mississippi #vertex #crispr #jenniferdoudna #anobelprize #african